Skip to main content

Advertisement

Table 5 complications in group A and B cases

From: A human MYBPC3 mutation appearing about 10 centuries ago results in a hypertrophic cardiomyopathy with delayed onset, moderate evolution but with a risk of sudden death

  Cardioversion Pacemaker Defibrillator Wall thinning Heart failure Heart transplantation
Group A (n) 2 (5.9%) 1 (2.9%) 1 (2.9%) 2 (5.9%) 2 (5.9%) 0
Group B (n) 5 (6.8%) 4 (5.5%) 8 (11.0%) 4 (5.5%) 11 (15.1%) 5 (6.8%)